Sep 14, 2026
Cellectis Pivots to Gene Editing in Major Overhaul

Cellectis SA (NASDAQ:CLLS) on Monday announced a strategic transformation to become an in vivo gene editing entity focused on long-lasting treatments for chronic diseases. Following the announcement, the stock fell over 27%. The board of directors approved the pivot on…

Sep 14, 2026
Bloom Energy Stock Slides Monday: What’s Going On?

Shares of Bloom Energy Corp. (NYSE:BE) are trading lower Monday morning as a shift in AI infrastructure sentiment combined with geopolitical escalation and rising interest rate expectations pressure high-beta energy stocks. Here’s what investors need to know. Bloom Energy shares…

Sep 14, 2026
Why Is Broadcom Stock Falling Monday?

Broadcom Inc. (NASDAQ) stock fell more than 4% in Monday’s premarket session amid a broader semiconductor selloff. Advanced Micro Devices Inc. (NASDAQ), NVIDIA Corp. (NASDAQ) and Marvell Technology Inc. (NASDAQ) also fell between 3% and 8%. AI Spending Concerns Weigh…

Sep 14, 2026
Cybersecurity Stocks Rally as AI Safety Debate Heats Up

CrowdStrike Holdings Inc. (NASDAQ:CRWD) and Palo Alto Networks Inc. (NASDAQ:PANW) shares are trading higher Monday, along with cybersecurity stocks broadly, following fresh warnings from top AI executives about the risks of advancing AI capabilities. CrowdStrike CEO George Kurtz pushed back…

Sep 14, 2026
Why Is Marvell Technology Stock Falling Monday?

Marvell Technology Inc. (NASDAQ:MRVL) stock fell about 8% in Monday’s premarket session as investors pulled back from AI-linked semiconductor stocks. Nasdaq futures are down 1.69% while S&P 500 futures have shed 0.69%. AI Spending Concerns Pressure Marvell Marvell’s decline came…

Sep 14, 2026
Leading And Lagging Sectors For September 14, 2026

Gainers Symbol Name Price Change ($) Change (%) Volume (NYSE:XLE) State Street Energy Select Sector SPDR ETF 66.17 1.03 1.58 720.1K (NYSE:XLP) State Street Consumer Staples Select Sector SPDR ETF 84.40 1.02 1.22 128.3K (NYSE:XLV) State Street Health Care Select…

Sep 14, 2026
Why Is AstraZeneca Stock Trading Higher Today?

AstraZeneca Plc (NYSE:AZN) reported updated clinical outcomes across its oncology portfolio, demonstrating sustained long-term survival advantages in lung cancer treatments alongside mixed findings in advanced breast cancer research. Long-Term Survival Gains In Early-Stage Lung Cancer Eight-year follow-up data released on…